We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
| CEO: |
Luke Miels |
| Chief Finance Officer: |
Julie Brown |
| Independent Non-Executive Director: |
Anne Beal, Harry (Hal) C. Dietz, Vishal Sikka, Elizabeth (Liz) McKee Anderson |
| Non-Executive Chairman: |
Jonathan Symonds |
| Non-Executive Director: |
Hal Barron , Wendy Becker , Jeannie Lee , Gavin Screaton, Roy Jakobs |
| Senior Independent Non-Executive Director: |
Charles Bancroft |
| Address: |
79 New Oxford Street, London, United Kingdom |
| Phone: |
+44 (0)20 8047 5000 |
| Fax: |
|
| Website: |
http://www.gsk.com/en-gb/ |
| Email: |
|